—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Summit Therapeutics PLC (SMMT) — Technical state

As of 2026-10-30 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 36 out of 100 (momentum 41 · quality 1 · valuation 55), as of 2026-11-01.
  • Signal: Downtrend stack — Trades -0.2% vs the 50-day and -0.9% vs the 200-day average, 45.2% below the 52-week high and +32.8% off the 52-week low. Computed from daily closes. (as of 2026-10-30)
  • Trend: Summit Therapeutics PLC trades 0.2% below its 50-day and 0.9% below its 200-day moving average. (as of 2026-10-30)

Summit Therapeutics develops cancer treatments, with its lead candidate ivonescimab, a bispecific antibody that blocks PD-1 signalling while also limiting blood-vessel growth around tumours. It is being tested in combination with chemotherapy for lung and colorectal cancers in late-stage trials, and the company sells across several regions worldwide.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the SMMT overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Downtrend stack

Trades -0.2% vs the 50-day and -0.9% vs the 200-day average, 45.2% below the 52-week high and +32.8% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the SMMT chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-10-30

Quick answers

What is the current Closelooknet signal on SMMT?

Downtrend stack — Trades -0.2% vs the 50-day and -0.9% vs the 200-day average, 45.2% below the 52-week high and +32.8% off the 52-week low. Computed from daily closes. As of 2026-10-30; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is SMMT above its 50-day and 200-day moving averages?

As of 2026-10-30, Summit Therapeutics PLC trades -0.2% below its 50-day and -0.9% below its 200-day average, with the 20-day -0.3% away.

How far is SMMT from its 52-week high?

45.2% below the 52-week high and 32.8% above the 52-week low, as of 2026-10-30.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.